Search
Nyxoah SA
NYXHAdd to Watchlist
1.400USD
-0.010-0.71%
Close 07-31 16:00（ET）Quotes delayed by 15 min
60.24MMarket Cap
LossP/E TTM
More Details of Nyxoah SA Company
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
Nyxoah SA Info
Ticker SymbolNYXH
Company nameNyxoah SA
IPO dateSep 18, 2020
CEOTaelman (Olivier)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endSep 18
AddressRue Edouard Belin 12
CityMONT-SAINT-GUIBERT
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryBelgium
Postal code1435
Phone3226121755
Websitehttps://www.nyxoah.com/
Ticker SymbolNYXH
IPO dateSep 18, 2020
CEOTaelman (Olivier)
Company Executives of Nyxoah SA
Name
Name/Position
Position
Shareholding
Change
Mr. Robert Taub
Mr. Robert Taub
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
14.44M
+70.15%
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Juergen Hambrecht, Ph.D.
Dr. Juergen Hambrecht, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Rita F. Johnson-Mills
Ms. Rita F. Johnson-Mills
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pierre Gianello, M.D.
Dr. Pierre Gianello, M.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Olivier Taelman
Mr. Olivier Taelman
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Mr. Christoph Eigenmann
Mr. Christoph Eigenmann
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Daniel G. Wildman
Mr. Daniel G. Wildman
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Francis Kim
Mr. Francis Kim
Chief Regulatory and Quality Officer
Chief Regulatory and Quality Officer
--
--
Dr. Maurits S. Boon
Dr. Maurits S. Boon
Chief Medical Officer
Chief Medical Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Robert Taub
Mr. Robert Taub
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
14.44M
+70.15%
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Juergen Hambrecht, Ph.D.
Dr. Juergen Hambrecht, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Rita F. Johnson-Mills
Ms. Rita F. Johnson-Mills
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pierre Gianello, M.D.
Dr. Pierre Gianello, M.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Olivier Taelman
Mr. Olivier Taelman
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
FAQs
Who are the top five shareholders of Nyxoah SA?
The top five shareholders of Nyxoah SA are: Mr. Robert Taub
How many institutions hold shares of Nyxoah SA (NYXH)?
As of 2026Q1, 79 institutions hold shares of Nyxoah SA, with a combined market value of approximately 9.38M, accounting for 21.47% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -824223.00.